Stevenson Mark P
SEC CIK 1387890 · EDGAR
BoughtSold
Most active insiders at IR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Reynal Vicente | See Remarks, Dir | — | $49.68M |
| 2 | Kini Vikram | SVP, CFO | — | $2.74M |
| 3 | Scheske Michael J | VP, CAO | — | $1.99M |
| 4 | Hepding Elizabeth Meloy | See Remarks | — | $1.77M |
| 5 | Schiesl Andrew R | See Remarks | — | $1.76M |
| 6 | Keene Kathleen M. | See Remarks | — | $1.19M |
| 7 | Satpathy Aurobind | Dir | $1.00M | — |
| 8 | Humphrey John | Dir | — | $412.4K |
| 9 | Swanenburg Michelle | Dir | — | — |
| 10 | Emmerich Matthew J | See Remarks | — | — |
| 15 | Stevenson Mark P | Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-02 | 2026-02-26 | IR | Ingersoll Rand | Stevenson Mark P | Dir | M - OptEx | — | +2,309 | 11.7K | +25% | — |
| D | 2025-02-28 | 2025-02-27 | IR | Ingersoll Rand | Stevenson Mark P | Dir | M - OptEx | — | +2,129 | 9,397 | +29% | — |
| D | 2024-02-26 | 2024-02-23 | IR | Ingersoll Rand | Stevenson Mark P | Dir | M - OptEx | — | +3,022 | 7,268 | +71% | — |
| D | 2023-08-08 | 2023-08-05 | IR | Ingersoll Rand | Stevenson Mark P | Dir | M - OptEx | — | +1,757 | 4,246 | +71% | — |
| 2022-03-01 | 2022-02-25 | TMO | Thermo Fisher Scientific | Stevenson Mark | COO, Retiring Executive VP | F - Tax | $549.83 | -1,880 | 62.1K | -3% | -$1.03M | |
| 2022-02-25 | 2022-02-23 | TMO | Thermo Fisher Scientific | Stevenson Mark | COO, Retiring Executive VP | A - Grant | $0.00 | +7,000 | 66.3K | +12% | $0 | |
| M | 2022-02-25 | 2022-02-23 | TMO | Thermo Fisher Scientific | Stevenson Mark | COO, Retiring Executive VP | F - Tax | $528.58 | -2,235 | 64.0K | -3% | -$1.18M |
| DM | 2021-12-03 | 2021-12-01 | TMO | Thermo Fisher Scientific | Stevenson Mark | EVP, COO | S - Sale+OE | $631.88 | -26.9K | 65.1K | -29% | -$17.01M |
| DM | 2021-12-03 | 2021-12-01 | TMO | Thermo Fisher Scientific | Stevenson Mark | EVP, COO | M - OptEx | $175.46 | +26.9K | 86.2K | +45% | +$4.72M |
| DM | 2021-11-03 | 2021-11-01+ | TMO | Thermo Fisher Scientific | Stevenson Mark | EVP, COO | S - Sale+OE | $635.36 | -53.9K | 59.9K | -47% | -$34.21M |
| DM | 2021-11-03 | 2021-11-01+ | TMO | Thermo Fisher Scientific | Stevenson Mark | EVP, COO | M - OptEx | $175.46 | +53.9K | 86.2K | +167% | +$9.45M |
| M | 2021-08-30 | 2021-08-26+ | TMO | Thermo Fisher Scientific | Stevenson Mark | EVP, COO | F - Tax | $550.52 | -2,196 | 60.4K | -4% | -$1.21M |
| 2021-08-26 | 2021-08-25 | TMO | Thermo Fisher Scientific | Stevenson Mark | EVP, COO | F - Tax | $548.08 | -635 | 61.5K | -1% | -$348.0K | |
| 2021-08-24 | 2021-08-23 | TMO | Thermo Fisher Scientific | Stevenson Mark | EVP, COO | F - Tax | $552.61 | -267 | 62.1K | -0.4% | -$147.5K | |
| DM | 2021-08-04 | 2021-08-02 | TMO | Thermo Fisher Scientific | Stevenson Mark | EVP, COO | S - Sale+OE | $535.38 | -26.9K | 71.2K | -27% | -$14.42M |
| DM | 2021-08-04 | 2021-08-02 | TMO | Thermo Fisher Scientific | Stevenson Mark | EVP, COO | M - OptEx | $175.46 | +26.9K | 76.9K | +54% | +$4.72M |
Purchase Sale Sale after option exercise All abbreviations